Westfield Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.16M | Sell |
42,901
-10,651
| -20% | -$1.23M | 0.02% | 206 |
|
|
2025
Q4 | $5.64M | Buy |
+53,552
| New | +$5.03M | 0.02% | 206 |
|
|
2025
Q1 | – | Sell |
-105,933
| Closed | -$10.5M | – | 268 |
|
|
2024
Q4 | $10.5M | Sell |
105,933
-11,233
| -10% | -$1.16M | 0.05% | 186 |
|
|
2024
Q3 | $13.3M | Buy |
117,166
+17,458
| +18% | +$2.07M | 0.06% | 188 |
|
|
2024
Q2 | $12.3M | Buy |
99,708
+5,892
| +6% | +$759K | 0.06% | 191 |
|
|
2024
Q1 | $12.4M | Buy |
93,816
+6,190
| +7% | +$763K | 0.07% | 191 |
|
|
2023
Q4 | $9.55M | Buy |
87,626
+806
| +0.9% | +$83.7K | 0.06% | 191 |
|
|
2023
Q3 | $8.94M | Buy |
86,820
+5,421
| +7% | +$584K | 0.06% | 180 |
|
|
2023
Q2 | $9.39M | Buy |
81,399
+4,890
| +6% | +$555K | 0.06% | 180 |
|
|
2023
Q1 | $8.14M | Buy |
76,509
+17,296
| +29% | +$1.87M | 0.06% | 182 |
|
|
2022
Q4 | $6.57M | Buy |
59,213
+3,861
| +7% | +$395K | 0.05% | 185 |
|
|
2022
Q3 | $4.77M | Sell |
55,352
-1,159
| -2% | -$103K | 0.04% | 196 |
|
|
2022
Q2 | $5.15M | Buy |
+56,511
| New | +$5.01M | 0.04% | 197 |
|
|
2021
Q3 | – | Sell |
-5,439
| Closed | -$423K | – | 253 |
|
|
2021
Q2 | $423K | Sell |
5,439
-3,519
| -39% | -$262K | ﹤0.01% | 238 |
|
|
2021
Q1 | $659K | Sell |
8,958
-2,014
| -18% | -$149K | ﹤0.01% | 230 |
|
|
2020
Q4 | $856K | Sell |
10,972
-67,103
| -86% | -$5.13M | 0.01% | 233 |
|
|
2020
Q3 | $6.18M | Sell |
78,075
-14,976
| -16% | -$1.17M | 0.04% | 196 |
|
|
2020
Q2 | $6.87M | Sell |
93,051
-8,735
| -9% | -$658K | 0.05% | 195 |
|
|
2020
Q1 | $7.47M | Buy |
101,786
+178
| +0.2% | +$14K | 0.07% | 185 |
|
|
2019
Q4 | $8.82M | Sell |
101,608
-346
| -0.3% | -$28.4K | 0.06% | 189 |
|
|
2019
Q3 | $8.19M | Sell |
101,954
-1,289
| -1% | -$103K | 0.07% | 190 |
|
|
2019
Q2 | $8.26M | Sell |
103,243
-2,221
| -2% | -$170K | 0.06% | 199 |
|
|
2019
Q1 | $8.37M | Sell |
105,464
-2,678
| -2% | -$200K | 0.06% | 203 |
|
|
2018
Q4 | $7.88M | Sell |
108,142
-765
| -0.7% | -$54K | 0.07% | 196 |
|
|
2018
Q3 | $7.37M | Buy |
108,907
+96,164
| +755% | +$6.13M | 0.05% | 212 |
|
|
2018
Q2 | $738K | Hold |
12,743
| – | – | 0.01% | 231 |
|
|
2018
Q1 | $662K | Hold |
12,743
| – | – | 0.01% | 234 |
|
|
2017
Q4 | $684K | Hold |
12,743
| – | – | 0.01% | 229 |
|
|
2017
Q3 | $779K | Hold |
12,743
| – | – | 0.01% | 229 |
|
|
2017
Q2 | $779K | Sell |
12,743
-82,137
| -87% | -$5M | 0.01% | 233 |
|
|
2017
Q1 | $5.75M | Buy |
94,880
+82,137
| +645% | +$4.98M | 0.05% | 225 |
|
|
2016
Q4 | $716K | Hold |
12,743
| – | – | 0.01% | 239 |
|
|
2016
Q3 | $759K | Hold |
12,743
| – | – | 0.01% | 236 |
|
|
2016
Q2 | $700K | Sell |
12,743
-7,860
| -38% | -$418K | 0.01% | 239 |
|
|
2016
Q1 | $1.04M | Hold |
20,603
| – | – | 0.01% | 229 |
|
|
2015
Q4 | $1.04M | Hold |
20,603
| – | – | 0.01% | 243 |
|
|
2015
Q3 | $971K | Hold |
20,603
| – | – | 0.01% | 228 |
|
|
2015
Q2 | $1.12M | Buy |
20,603
+2,254
| +12% | +$126K | 0.01% | 250 |
|
|
2015
Q1 | $1.01M | Hold |
18,349
| – | – | 0.01% | 276 |
|
|
2014
Q4 | $994K | Hold |
18,349
| – | – | 0.01% | 278 |
|
|
2014
Q3 | $1.04M | Hold |
18,349
| – | – | 0.01% | 267 |
|
|
2014
Q2 | $1.01M | Hold |
18,349
| – | – | 0.01% | 270 |
|
|
2014
Q1 | $994K | Hold |
18,349
| – | – | 0.01% | 285 |
|
|
2013
Q4 | $876K | Sell |
18,349
-3,397,068
| -99% | -$155M | 0.01% | 281 |
|
|
2013
Q3 | $155M | Sell |
3,415,417
-137,420
| -4% | -$6.27M | 0.99% | 21 |
|
|
2013
Q2 | $157M | Buy |
+3,552,837
| New | +$159M | 1.08% | 14 |
|
Other funds holding MRK
VCM
VPM
Westfield Capital Management's MRK Position: Q1 2026 in Review
Westfield Capital Management reduced its Merck (MRK) stake by 20% in Q1 2026, selling an estimated $1.23M and leaving 42,901 shares worth $5.16M. The position accounts for 0.02% of the portfolio, ranked #206.
Westfield Capital Management first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $157M in Q2 2013. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Westfield Capital Management held 42,901 shares of Merck worth $5.16M as of Q1 2026.
- Westfield Capital Management sold 10,651 Merck shares in Q1 2026, an estimated $1.23M.
- Merck made up 0.02% of Westfield Capital Management's portfolio in Q1 2026, its #206 holding.
- Westfield Capital Management first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
- Westfield Capital Management's Merck position peaked at $157M in Q2 2013.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.